Pfizer has a total of 88893 patents globally, out of which 23509 have been granted. Of these 88893 patents, more than 20% patents are active. United States of America is where Pfizer has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Pfizer.
Pfizer was founded in the year 1849. The Company operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices and consumer healthcare products for oncology, inflammation, cardiovascular and other therapeutic areas.
Do read about some of the most popular patents of Pfizer which have been covered by us in this article and also you can find Pfizer patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pfizer patent portfolio.
How many patents does the founder and the CEO of Pfizer have?
The founder Charles Pfizer has 0 patent and Charles F. Erhart has 0 patent and CEO Albert Bourla has 0 patent.
How many patents does Pfizer have?
Pfizer has a total of 88893 patents globally. These patents belong to 12785 unique patent families. Out of 88893 patents, 18413 patents are active.
How Many Patents did Pfizer File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Pfizer Applications Filed | Pfizer Patents Granted |
2023 | 294 | 729 |
2022 | 704 | 829 |
2021 | 1554 | 954 |
2020 | 945 | – |
2019 | 864 | – |
2018 | 506 | – |
2017 | 881 | 1013 |
2016 | 1410 | 821 |
2015 | 1815 | 809 |
2014 | 1396 | 228 |
2013 | 1620 | 838 |
2012 | 1717 | 894 |
Which Pfizer Drug Patents are Expiring in the Next 10 Years?
The patent no. US8420650B2 which is expiring in Jul, 2029, describes changing in poly(ADP-ribose)polymerase (PARP) activity to treat or prevent diseases related to PARP. This involves giving a subject a therapeutic amount of compounds represented by Formula (I) and Formula (II), along with ionizing radiation, chemotherapy, or both.
Given below is the list of few drugs patented by Pfizer accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
Drug Name | Patent Number | Patent Title | Patent Expiration |
Talzenna | US8420650B2 | Dihydropyridophthalazinone Inhibitors… | Jul, 2029 |
Toviaz | US7807715B2 | Pharmaceutical Compositions Compr… | Jun, 2027 |
Vizimpro | US10596162B2 | Method For Treating Gefitinib… | Feb, 2026 |
Vyndaqel | US7214696B2 | Compositions And Methods For… | Dec, 2024 |
Nurtec Odt | US11083724B2 | Rimegepant For CGRP Related Dis… | Mar, 2039 |
Interested in knowing about Pfizer’s Drug Patents Expiring in the next 10 years?
How many Pfizer patents are Alive/Dead?
How Many Patents did Pfizer File in Different Countries?
Countries in which Pfizer Filed Patents
Country | Patents |
United States Of America | 8181 |
Japan | 5474 |
Europe | 5394 |
Mexico | 3765 |
Australia | 3724 |
Canada | 3104 |
Brazil | 2718 |
China | 2628 |
India | 2625 |
Hong Kong (S.A.R.) | 2383 |
Korea (South) | 2290 |
Germany | 2076 |
Taiwan | 2062 |
Argentina | 1965 |
Singapore | 1902 |
Austria | 1886 |
Spain | 1734 |
South Africa | 1652 |
Israel | 1619 |
New Zealand | 1382 |
Denmark | 1277 |
Chile | 1216 |
Malaysia | 1181 |
Indonesia | 1088 |
Portugal | 1087 |
Norway | 1059 |
Poland | 1016 |
Russia | 871 |
Viet Nam | 856 |
Peru | 797 |
Slovenia | 722 |
Tunisia | 701 |
Costa Rica | 675 |
Eurasia | 658 |
Philippines | 633 |
Hungary | 584 |
Morocco | 570 |
Africa | 558 |
Uruguay | 531 |
Slovakia | 511 |
Colombia | 506 |
Ecuador | 465 |
Malta | 437 |
Panama | 433 |
Dominican Republic | 402 |
Estonia | 401 |
Croatia | 386 |
Ukraine | 379 |
Saudi Arabia | 355 |
Mongolia | 311 |
Czech Republic | 293 |
Serbia | 275 |
Cyprus | 274 |
Georgia | 274 |
Iceland | 247 |
Netherlands | 243 |
Thailand | 238 |
Bulgaria | 204 |
United Kingdom | 203 |
Yugoslavia/Serbia and Montenegro | 199 |
El Salvador | 183 |
Uzbekistan | 165 |
Macao | 165 |
Cuba | 162 |
Italy | 148 |
Finland | 141 |
Nicaragua | 128 |
Africa | 121 |
Honduras | 106 |
Egypt | 98 |
Guatemala | 87 |
Algeria | 76 |
Turkey | 75 |
Brunei | 75 |
Albania | 73 |
Lithuania | 60 |
Montenegro | 59 |
Paraguay | 58 |
Bolivia | 52 |
Gulf Cooperation Council | 47 |
Pakistan | 45 |
Bangladesh | 33 |
Ireland | 32 |
Romania | 29 |
Luxembourg | 25 |
Lebanon | 24 |
Republic of Moldova | 22 |
San Marino | 15 |
Belarus | 15 |
Kenya | 14 |
Former Yugoslav Republic of Macedonia | 11 |
Belgium | 11 |
Sweden | 11 |
United Arab Emirates | 10 |
Switzerland | 8 |
Latvia | 8 |
France | 7 |
Trinidad and Tobago | 7 |
Rwanda | 6 |
Greece | 5 |
Jordan | 4 |
Belize | 3 |
Botswana | 1 |
Brunei | 1 |
Kazakhstan | 1 |
Tajikistan | 1 |
Where are Research Centres of Pfizer Patents Located?
10 Best Pfizer Patents
US20040167572A1 is the most popular patent in the Pfizer portfolio. It has received 1728 citations so far from companies like Tyco Healthcare, Boston Scientific Scimed and Atrium Medical Corporation.
Below is the list of 10 most cited patents of Pfizer:
Publication Number | Citation Count |
US20040167572A1 | 1728 |
US6534055B1 | 1408 |
US6682736B1 | 1208 |
US7144575B2 | 1111 |
WO2004056875A1 | 952 |
WO2011143545A1 | 908 |
US6808710B1 | 847 |
WO2003077914A1 | 718 |
WO2004056786A2 | 716 |
US6603008B1 | 592 |
How many inventions of other companies were rejected due to Pfizer patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Pfizer invention. They couldn’t because Pfizer had protected those before them.
Examiners at the USPTO referred 1722 Pfizer patents in 7108 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Pfizer patent portfolio are Protia, Wyeth and Array Biopharma.
List of the Companies whose Patents were rejected citing Pfizer –
Company | Number of Patent Applications that faced Rejection Citing Pfizer Patents | Number of Rejections (102 & 103) |
Protia | 45 | 58 |
Wyeth | 35 | 100 |
Array Biopharma | 35 | 67 |
Genentech | 32 | 66 |
Merck Sharp & Dohme | 27 | 70 |
Novartis | 25 | 43 |
Sanofi-Aventis Deutschland | 23 | 63 |
Arena Pharmaceuticals | 23 | 35 |
Glaxosmithkline Biologicals | 22 | 34 |
Amgen | 21 | 63 |
Count of 102 and 103 Type Rejections based on Pfizer Patents
Top Pfizer Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US6603008B1 | 153 |
US20040131552A1 | 30 |
US20100068285A1 | 16 |
US20070286822A1 | 16 |
US20080055154A1 | 14 |
US20070135908A1 | 14 |
US20080233197A1 | 13 |
US20040265230A1 | 13 |
US20050214383A1 | 12 |
US20040133002A1 | 12 |
US20030144220A1 | 11 |
US7401713B2 | 10 |
US20070228073A1 | 10 |
US20080051399A1 | 10 |
US20050004663A1 | 10 |
What Percentage of Pfizer US Patent Applications were Granted?
Pfizer (Excluding its subsidiaries) has filed 4882 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2269 have been granted leading to a grant rate of 70.6%.
Below are the key stats of Pfizer patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Pfizer?
Law Firm | Total Applications | Success Rate |
Pfizer Inc | 1661 | 61.16% |
Gregg C Benson | 579 | 64.61% |
Peter C Richardson | 418 | 81.94% |
Paul H Ginsburg | 233 | 71.31% |
Charles J Knuth | 165 | 74.55% |
Zoetis | 114 | 87.61% |
Johnson & Johnson | 80 | 71.43% |
Dr Peter C Richardson | 70 | 95.92% |
Ronald S Courtney | 58 | 100.00% |
Chernoff Vilhauer Mcclung & Stenzel | 55 | 56.52% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Pfizer’s key innovation segments?
What Technologies are Covered by Pfizer?
The chart below distributes patents filed by Pfizer in different countries on the basis of the technology protected in patents. It also represents the markets where Pfizer thinks it’s important to protect particular technology inventions.
R&D Focus: How Pfizer search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Pfizer?